Contributors |
|
xvii | |
Reviewers |
|
xix | |
Preface |
|
xxi | |
|
|
1 | (198) |
|
1 Assessment of Progressive Care Patients and Their Families |
|
|
3 | (14) |
|
|
|
3 | (2) |
|
|
4 | (1) |
|
|
4 | (1) |
|
Comprehensive Initial Assessment |
|
|
4 | (1) |
|
|
4 | (1) |
|
Patient Safety Considerations in Admission Assessments |
|
|
4 | (1) |
|
Prearrival Assessment: Before the Action Begins |
|
|
5 | (1) |
|
Arrival Quick Check Assessment |
|
|
5 | (3) |
|
|
6 | (1) |
|
Circulation and Cerebral Perfusion |
|
|
7 | (1) |
|
|
7 | (1) |
|
Drugs and Diagnostic Tests |
|
|
7 | (1) |
|
|
7 | (1) |
|
Comprehensive Initial Assessment |
|
|
8 | (7) |
|
|
9 | (1) |
|
|
9 | (1) |
|
Physical Assessment by Body System |
|
|
10 | (5) |
|
Transition/Discharge Planning |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
16 | (1) |
|
Progressive Care Assessment |
|
|
16 | (1) |
|
|
16 | (1) |
|
2 Planning Care for Progressive Care Patients and Their Families |
|
|
17 | (16) |
|
|
Multidisciplinary Plan of Care |
|
|
18 | (1) |
|
Planning Care Through Staffing Considerations |
|
|
18 | (1) |
|
Patient Safety Considerations in Planning Care |
|
|
19 | (1) |
|
Prevention of Common Complications |
|
|
20 | (4) |
|
|
20 | (1) |
|
|
20 | (1) |
|
Hospital-Acquired Infections |
|
|
20 | (1) |
|
|
21 | (1) |
|
Sleep Pattern Disturbance |
|
|
22 | (1) |
|
|
22 | (2) |
|
Patient and Family Education |
|
|
24 | (1) |
|
Assessment of Learning Readiness |
|
|
24 | (1) |
|
Strategies to Address Patient and Family Education |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (2) |
|
Transporting the Progressive Care Patient |
|
|
27 | (4) |
|
Assessment of Risk for Complications |
|
|
27 | (1) |
|
Level of Care Required During Transport |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (1) |
|
Transitioning to the Next Stage of Care |
|
|
31 | (1) |
|
Supporting Patients and Their Families During the Dying Process |
|
|
31 | (1) |
|
|
31 | (2) |
|
Family Interventions/Visitation |
|
|
31 | (1) |
|
|
32 | (1) |
|
Patient and Family Education |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
32 | (1) |
|
Transport of Critically Ill Patients |
|
|
32 | (1) |
|
|
32 | (1) |
|
3 Interpretation and Management of Basic Cardiac Rhythms |
|
|
33 | (34) |
|
|
|
33 | (1) |
|
ECG Waveforms, Complexes, and Intervals |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
Basic Electrocardiography |
|
|
35 | (1) |
|
|
35 | (3) |
|
Determination of the Heart Rate |
|
|
38 | (1) |
|
Determination of Cardiac Rhythm |
|
|
38 | (1) |
|
|
39 | (1) |
|
Rhythms Originating in the Sinus Node |
|
|
39 | (2) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
Arrhythmias Originating in the Atria |
|
|
41 | (9) |
|
Premature Atrial Complexes |
|
|
41 | (1) |
|
Wandering Atrial Pacemaker |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
43 | (2) |
|
|
45 | (4) |
|
Supraventricular Tachycardia |
|
|
49 | (1) |
|
Arrhythmias Originating in the Atrioventricular Junction |
|
|
50 | (1) |
|
Premature Junctional Complexes |
|
|
50 | (1) |
|
Junctional Rhythm, Accelerated Junctional Rhythm, and Junctional Tachycardia |
|
|
51 | (1) |
|
Arrhythmias Originating in the Ventricles |
|
|
51 | (4) |
|
Premature Ventricular Complexes |
|
|
51 | (1) |
|
Ventricular Rhythm and Accelerated Ventricular Rhythm |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
55 | (3) |
|
First-Degree Atrioventricular Block |
|
|
55 | (1) |
|
Second-Degree Atrioventricular Block |
|
|
55 | (1) |
|
High-Grade Atrioventricular Block |
|
|
56 | (1) |
|
Third-Degree Atrioventricular Block (Complete Block) |
|
|
57 | (1) |
|
|
58 | (4) |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
Components of a Pacing System |
|
|
60 | (1) |
|
Basics of Pacemaker Operation |
|
|
60 | (2) |
|
Initiating Transvenous Ventricular Pacing |
|
|
62 | (1) |
|
Initiating Epicardial Pacing |
|
|
62 | (1) |
|
External (Transcutaneous) Pacemakers |
|
|
62 | (1) |
|
Defibrillation and Cardioversion |
|
|
62 | (2) |
|
|
62 | (1) |
|
Automatic External Defibrillators |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (3) |
|
|
65 | (2) |
|
|
67 | (26) |
|
|
|
67 | (7) |
|
|
67 | (2) |
|
Components of Cardiac Output/Cardiac Index |
|
|
69 | (1) |
|
Stroke Volume and Stroke Volume Index |
|
|
70 | (1) |
|
|
70 | (1) |
|
Factors Affecting Stroke Volume/Stroke Volume Index |
|
|
70 | (4) |
|
Basic Components of Hemodynamic Monitoring Systems |
|
|
74 | (2) |
|
Pulmonary Artery Catheter |
|
|
74 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
Pressure Bag and Flush Device |
|
|
74 | (2) |
|
|
76 | (1) |
|
Obtaining Accurate CVP and Arterial Values |
|
|
76 | (2) |
|
|
76 | (1) |
|
Leveling the Transducer to the Catheter Tip |
|
|
76 | (1) |
|
Calibration of the Transducer/Amplifier System |
|
|
77 | (1) |
|
Ensuring Accurate Waveform Transmission |
|
|
77 | (1) |
|
Insertion and Removal of Catheters |
|
|
78 | (3) |
|
|
78 | (2) |
|
|
80 | (1) |
|
Obtaining and Interpreting Hemodynamic Waveforms |
|
|
81 | (5) |
|
|
81 | (1) |
|
|
81 | (4) |
|
Artifacts in Hemodynamic Waveforms: Respiratory Influence |
|
|
85 | (1) |
|
Continuous Mixed and Central Venous Oxygen Monitoring (Svo2/Scvo2) |
|
|
86 | (1) |
|
Svo2/Scvo2 Monitoring Principles |
|
|
86 | (1) |
|
Minimally Invasive Hemodynamic Monitoring |
|
|
87 | (1) |
|
|
87 | (1) |
|
Pulse Contour Measurement |
|
|
88 | (1) |
|
|
88 | (5) |
|
|
88 | (1) |
|
Minimally Invasive Hemodynamic Monitoring |
|
|
89 | (1) |
|
|
90 | (2) |
|
Evidence-Based Practice Guidelines |
|
|
92 | (1) |
|
5 Airway and Ventilatory Management |
|
|
93 | (40) |
|
|
|
Tests, Monitoring Systems and Respiratory Assessment Techniques |
|
|
93 | (8) |
|
Arterial Blood Gas Monitoring |
|
|
93 | (5) |
|
Venous Blood Gas Monitoring |
|
|
98 | (1) |
|
|
98 | (2) |
|
Assessing Pulmonary Function |
|
|
100 | (1) |
|
|
101 | (6) |
|
|
101 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
Esophageal Tracheal Airway |
|
|
102 | (1) |
|
|
102 | (3) |
|
|
105 | (2) |
|
|
107 | (3) |
|
|
107 | (1) |
|
|
107 | (3) |
|
Basic Ventilatory Management |
|
|
110 | (19) |
|
|
110 | (1) |
|
|
110 | (1) |
|
Patient-Ventilator System |
|
|
111 | (3) |
|
|
114 | (1) |
|
Complications of Mechanical Ventilation |
|
|
115 | (2) |
|
Weaning From Short-Term Mechanical Ventilation |
|
|
117 | (2) |
|
Weaning From Long-Term Mechanical Ventilation |
|
|
119 | (1) |
|
Respiratory Fatigue, Rest, and Conditioning |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
Systematic Institutional Initiatives for the Management of the LTMV Patient Population |
|
|
123 | (1) |
|
Troubleshooting Ventilators |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
125 | (3) |
|
|
128 | (1) |
|
|
129 | (4) |
|
|
129 | (1) |
|
|
130 | (1) |
|
Weaning From Mechanical Ventilation |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (2) |
|
6 Pain and Sedation Management |
|
|
133 | (18) |
|
|
|
Physiologic Mechanisms of Pain |
|
|
133 | (2) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
A Multimodal Approach to Pain Management |
|
|
136 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
136 | (2) |
|
|
138 | (1) |
|
|
138 | (3) |
|
|
138 | (1) |
|
|
139 | (1) |
|
Patient-Controlled Analgesia |
|
|
139 | (1) |
|
Switching From IV to Oral Opioid Analgesia |
|
|
140 | (1) |
|
|
141 | (2) |
|
|
142 | (1) |
|
Epidural Local Anesthetics |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
144 | (1) |
|
Deep Breathing and Progressive Relaxation |
|
|
144 | (1) |
|
|
145 | (1) |
|
Special Considerations for Pain Management in the Elderly |
|
|
145 | (1) |
|
|
145 | (1) |
|
|
145 | (1) |
|
|
145 | (4) |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
147 | (1) |
|
Goals of Sedation, Monitoring, and Management |
|
|
147 | (2) |
|
|
149 | (2) |
|
|
149 | (1) |
|
|
150 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
150 | (1) |
|
|
151 | (30) |
|
|
|
151 | (1) |
|
Medication Administration Methods |
|
|
152 | (1) |
|
|
152 | (1) |
|
Intramuscular or Subcutaneous |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
153 | (1) |
|
Central Nervous System Pharmacology |
|
|
153 | (8) |
|
|
153 | (3) |
|
|
156 | (2) |
|
|
158 | (3) |
|
Cardiovascular System Pharmacology |
|
|
161 | (6) |
|
|
161 | (1) |
|
|
161 | (3) |
|
|
164 | (2) |
|
Vasodilators and Remodeling Agents |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (2) |
|
|
168 | (1) |
|
|
168 | (1) |
|
|
169 | (3) |
|
|
169 | (1) |
|
|
170 | (1) |
|
|
170 | (1) |
|
Gastrointestinal Pharmacology |
|
|
170 | (1) |
|
|
170 | (1) |
|
Acute Peptic Ulcer Bleeding |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
173 | (4) |
|
|
173 | (2) |
|
|
175 | (1) |
|
Direct Thrombin Inhibitors |
|
|
175 | (1) |
|
Glycoprotein IIb/IIIa Inhibitor |
|
|
175 | (1) |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
177 | (1) |
|
Special Dosing Considerations |
|
|
178 | (1) |
|
Drug Disposition in the Elderly |
|
|
178 | (1) |
|
Therapeutic Drug Monitoring |
|
|
178 | (1) |
|
|
179 | (2) |
|
|
179 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
179 | (2) |
|
8 Ethical and Legal Considerations |
|
|
|
|
The Foundation for Ethical Decision Making |
|
|
181 | (7) |
|
Professional Codes and Standards |
|
|
181 | (1) |
|
Position Statements and Guidelines |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
183 | (3) |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
187 | (1) |
|
The Process of Ethical Analysis |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
Contemporary Ethical Issues |
|
|
188 | (5) |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
190 | (2) |
|
|
192 | (1) |
|
Building an Ethical Environment |
|
|
193 | (1) |
|
|
193 | (1) |
|
Provide Information and Clarify Issues |
|
|
193 | (1) |
|
|
194 | (1) |
|
Engage in Collaborative Decision Making |
|
|
194 | (1) |
|
|
194 | (5) |
|
Professional Codes, Standards, and Position Statements |
|
|
195 | (1) |
|
Evidence-Based Guidelines |
|
|
195 | (1) |
|
On-line References of Interest: Related to Legal and Ethical Considerations |
|
|
195 | (4) |
|
Section II Pathologic Conditions |
|
|
|
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
199 | (4) |
|
|
199 | (1) |
|
|
199 | (3) |
|
Percutaneous Coronary Interventions |
|
|
202 | (1) |
|
Other Percutaneous Coronary Interventions |
|
|
202 | (1) |
|
|
203 | (25) |
|
Acute Ischemic Heart Disease |
|
|
203 | (11) |
|
Electrophysiology Studies |
|
|
214 | (1) |
|
|
214 | (7) |
|
|
221 | (4) |
|
|
225 | (3) |
|
|
228 | (3) |
|
|
228 | (1) |
|
Coronary Revascularization |
|
|
228 | (1) |
|
Acute Ischemic Heart Disease |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
229 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
229 | (2) |
|
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
231 | (7) |
|
|
231 | (7) |
|
Computed Tomography and Magnetic Resonance Imaging |
|
|
236 | (1) |
|
|
|
Angiograms/CTPA and V/Q Scans |
|
|
236 | (1) |
|
|
237 | (1) |
|
Thoracic Surgery and Procedures |
|
|
237 | (1) |
|
|
238 | (20) |
|
Acute Respiratory Failure |
|
|
238 | (5) |
|
Acute Respiratory Distress Syndrome (ARDS) |
|
|
243 | (1) |
|
Acute Respiratory Failure in the Patient with Chronic Obstructive Pulmonary Disease |
|
|
244 | (3) |
|
Acute Respiratory Failure in the Patient with Asthma |
|
|
247 | (3) |
|
Interstitial Lung Disease |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
251 | (4) |
|
|
255 | (3) |
|
|
258 | (3) |
|
Critical Care Management of Respiratory Problems |
|
|
258 | (1) |
|
Chest X-Ray Interpretation |
|
|
258 | (1) |
|
|
258 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
258 | (3) |
|
|
261 | (18) |
|
|
|
261 | (7) |
|
Sepsis and Multiple Organ Dysfunction Syndrome |
|
|
261 | (7) |
|
|
268 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
268 | (5) |
|
Complex Wounds and Pressure Ulcers |
|
|
273 | (1) |
|
|
273 | (1) |
|
Healthcare Acquired Infections |
|
|
274 | (2) |
|
Selected Infectious Diseases |
|
|
276 | (1) |
|
|
276 | (3) |
|
|
276 | (1) |
|
|
277 | (1) |
|
Complex Wounds and Pressure Ulcers |
|
|
277 | (1) |
|
Healthcare Acquired Infections |
|
|
278 | (1) |
|
Selected Infectious Diseases |
|
|
278 | (1) |
|
|
279 | (24) |
|
|
Special Assessment Techniques and Diagnostic Tests |
|
|
279 | (6) |
|
|
279 | (1) |
|
|
280 | (1) |
|
Full Outline of UnResponsiveness (FOUR) Score |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
283 | (1) |
|
Cranial Nerve Assessment and Assessment of Brain Stem Function |
|
|
283 | (2) |
|
Vital Sign Alterations in Neurologic Dysfunction |
|
|
285 | (1) |
|
|
285 | (4) |
|
|
285 | (2) |
|
|
287 | (1) |
|
Magnetic Resonance Imaging |
|
|
287 | (1) |
|
Cerebral (Catheter) Angiography |
|
|
288 | (1) |
|
Transcranial Doppler Ultrasound |
|
|
288 | (1) |
|
|
288 | (1) |
|
Electromyography/Nerve Conduction Studies |
|
|
289 | (1) |
|
|
289 | (3) |
|
|
289 | (1) |
|
Causes of Increased Intracranial Pressure |
|
|
289 | (2) |
|
|
291 | (1) |
|
Principles of Management of Increased ICP |
|
|
291 | (1) |
|
|
292 | (4) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
292 | (1) |
|
|
293 | (1) |
|
|
294 | (1) |
|
Principles of Management of Acute Ischemic Stroke |
|
|
294 | (2) |
|
|
296 | (1) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
296 | (1) |
|
|
296 | (1) |
|
|
296 | (1) |
|
Principles of Management of Intracerebral Hemorrhage |
|
|
296 | (1) |
|
|
297 | (1) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
297 | (1) |
|
|
297 | (1) |
|
|
298 | (1) |
|
Principles of Management of Seizures |
|
|
298 | (1) |
|
Infections of the Central Nervous System |
|
|
298 | (1) |
|
|
298 | (1) |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
299 | (1) |
|
Amyotrophic Lateral Sclerosis |
|
|
299 | (1) |
|
|
300 | (3) |
|
Assessment and Diagnostic Testing |
|
|
300 | (1) |
|
|
300 | (1) |
|
Acute Ischemic Stroke and Hemorrhagic Stroke |
|
|
300 | (1) |
|
|
300 | (1) |
|
Infections of the Central Nervous System |
|
|
301 | (1) |
|
|
301 | (1) |
|
|
301 | (2) |
|
13 Hematologic and Immune Systems |
|
|
303 | (14) |
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
303 | (3) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
304 | (1) |
|
|
304 | (1) |
|
|
304 | (1) |
|
Total White Blood Cell Count |
|
|
304 | (1) |
|
White Blood Cell Differential |
|
|
305 | (1) |
|
|
305 | (1) |
|
|
305 | (1) |
|
Additional Tests and Procedures |
|
|
306 | (1) |
|
|
306 | (8) |
|
|
306 | (2) |
|
|
308 | (2) |
|
|
310 | (4) |
|
|
314 | (3) |
|
|
314 | (1) |
|
Immunocompromised Patient |
|
|
315 | (1) |
|
|
315 | (2) |
|
14 Gastrointestinal System |
|
|
317 | (32) |
|
|
|
|
|
|
317 | (20) |
|
Acute Upper Gastrointestinal Bleeding |
|
|
317 | (8) |
|
|
325 | (5) |
|
|
330 | (2) |
|
|
|
|
332 | (1) |
|
|
333 | (2) |
|
Bariatric (Weight Loss) Surgery |
|
|
335 | (1) |
|
|
335 | (2) |
|
Nutritional Support for Acutely Ill Patients |
|
|
337 | (6) |
|
|
337 | (1) |
|
Nutritional Case: Special Populations |
|
|
337 | (1) |
|
Postgastrectomy Syndromes |
|
|
338 | (1) |
|
|
339 | (1) |
|
|
340 | (1) |
|
|
341 | (1) |
|
|
341 | (1) |
|
Osmolality or Hypertonicity of Formula |
|
|
341 | (1) |
|
|
342 | (1) |
|
Flow Rates and Hours of Infusion |
|
|
342 | (1) |
|
|
343 | (1) |
|
|
343 | (6) |
|
|
343 | (1) |
|
|
344 | (1) |
|
|
344 | (1) |
|
Intestinal Ischemia/Bowel Obstruction |
|
|
344 | (1) |
|
|
345 | (2) |
|
On-line References of Interest |
|
|
347 | (1) |
|
Bariatric (Gastric Bypass) Surgery |
|
|
347 | (2) |
|
|
349 | (16) |
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
349 | (1) |
|
|
349 | (9) |
|
|
349 | (5) |
|
Life-Threatening Electrolyte Imbalances |
|
|
354 | (4) |
|
Renal Replacement Therapy |
|
|
358 | (5) |
|
|
359 | (1) |
|
Dialyzer/Hemofilters/Dialysate |
|
|
360 | (1) |
|
|
360 | (2) |
|
Indications for and Efficacy of Renal Replacement Therapy Modes |
|
|
362 | (1) |
|
General Renal Replacement Therapy Interventions |
|
|
362 | (1) |
|
|
363 | (2) |
|
General Renal and Electrolyte |
|
|
363 | (1) |
|
|
363 | (1) |
|
Renal Replacement Therapy |
|
|
363 | (1) |
|
|
363 | (2) |
|
|
365 | (16) |
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
365 | (2) |
|
|
365 | (2) |
|
|
367 | (12) |
|
|
367 | (1) |
|
Hyperglycemic Emergencies |
|
|
368 | (6) |
|
|
374 | (1) |
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion |
|
|
375 | (2) |
|
|
377 | (2) |
|
|
379 | (2) |
|
|
379 | (1) |
|
Hyperglycemia, DKA, and HHS |
|
|
379 | (1) |
|
SIADH and Diabetes Insipidus |
|
|
379 | (2) |
|
|
381 | (16) |
|
|
|
Specialized Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
381 | (6) |
|
Primary and Secondary Trauma Survey Assessment |
|
|
381 | (2) |
|
|
383 | (1) |
|
|
384 | (2) |
|
Physiologic Consequences of Trauma |
|
|
386 | (1) |
|
Common Injuries in the Trauma Patient |
|
|
387 | (6) |
|
|
387 | (3) |
|
|
390 | (1) |
|
|
391 | (2) |
|
Complications of Traumatic Injury in Severe Multisystem Trauma |
|
|
393 | (2) |
|
Acute Respiratory Distress Syndrome |
|
|
394 | (1) |
|
|
394 | (1) |
|
Systemic Inflammatory Response Syndrome |
|
|
395 | (1) |
|
Psychological Consequences of Trauma |
|
|
395 | (1) |
|
|
396 | (1) |
|
|
396 | (1) |
|
Selected Online References |
|
|
396 | (1) |
|
|
396 | (1) |
|
Section III Advanced Concepts in Caring for the Critically Ill Patient |
|
|
397 | (96) |
|
|
399 | (42) |
|
|
The 12-Lead Electrocardiogram |
|
|
399 | (19) |
|
|
403 | (1) |
|
|
404 | (4) |
|
|
408 | (6) |
|
|
414 | (4) |
|
Advanced Arrhythmia Interpretation |
|
|
418 | (9) |
|
Supraventricular Tachycardias |
|
|
418 | (4) |
|
Polymorphic Ventricular Tachycardias |
|
|
422 | (2) |
|
Differentiating Wide QRS Beats and Rhythms |
|
|
424 | (3) |
|
|
427 | (2) |
|
|
427 | (1) |
|
Choosing the Best Leads for ST-Segment Monitoring |
|
|
427 | (2) |
|
|
429 | (9) |
|
Evaluating Pacemaker Function |
|
|
431 | (1) |
|
|
431 | (3) |
|
|
434 | (4) |
|
|
438 | (3) |
|
|
439 | (2) |
|
19 Advanced Cardiovascular Concepts |
|
|
441 | (28) |
|
|
|
441 | (25) |
|
|
441 | (5) |
|
|
446 | (6) |
|
|
452 | (2) |
|
|
454 | (4) |
|
|
458 | (5) |
|
Ventricular Assist Devices |
|
|
463 | (3) |
|
|
466 | (3) |
|
|
466 | (1) |
|
|
466 | (1) |
|
|
467 | (1) |
|
|
467 | (1) |
|
|
467 | (1) |
|
Thoraco-Abdominal Aneurysms |
|
|
467 | (1) |
|
Ventricular Assist Devices |
|
|
467 | (1) |
|
|
468 | (1) |
|
Evidence-Based Practice Guidelines |
|
|
468 | (1) |
|
20 Advanced Neurologic Concepts |
|
|
469 | (24) |
|
|
|
469 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
469 | (1) |
|
|
469 | (1) |
|
|
470 | (1) |
|
Principles of Management of Aneurysmal Subarachnoid Hemorrhage |
|
|
471 | (3) |
|
|
474 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
474 | (2) |
|
|
476 | (1) |
|
|
477 | (1) |
|
Principles of Management of Traumatic Brain Injury |
|
|
477 | (2) |
|
Traumatic Spinal Cord Injury |
|
|
479 | (8) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
479 | (1) |
|
|
479 | (2) |
|
|
481 | (1) |
|
Principles of Management of Acute Spinal Cord Injury |
|
|
481 | (5) |
|
Future Spinal Cord Injury Treatment |
|
|
486 | (1) |
|
|
487 | (2) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
487 | (1) |
|
|
487 | (1) |
|
|
487 | (1) |
|
Principles of Management of Intracranial Tumors |
|
|
488 | (1) |
|
Special Considerations: Transsphenoidal Resection of Pituitary Tumors |
|
|
489 | (1) |
|
Special Procedures: Invasive Monitoring of Intracranial Pressure |
|
|
489 | (2) |
|
Intracranial Pressure Waveforms |
|
|
490 | (1) |
|
Special Procedures: Management of a Patient With a Lumbar Drain |
|
|
491 | (1) |
|
|
491 | (2) |
|
|
491 | (1) |
|
|
492 | (1) |
|
|
492 | (1) |
|
|
492 | (1) |
|
Intracranial Pressure Monitoring |
|
|
492 | (1) |
|
Evidence-Based Guidelines |
|
|
492 | (1) |
|
Section IV Key Reference Information |
|
|
493 | (30) |
|
|
495 | (2) |
|
|
|
497 | (14) |
|
|
23 Advanced Cardiac Life Support Algorithms |
|
|
511 | (4) |
|
|
24 Cardiac Rhythms, ECG Characteristics, and Treatment Guide |
|
|
515 | (8) |
|
Index |
|
523 | |